probucol has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalinina, TS | 1 |
| Nerobkova, LN | 1 |
| Voronina, TA | 1 |
| Stovbun, SV | 1 |
| Litvin, AA | 1 |
| Sergienko, VI | 1 |
1 other study available for probucol and Autosomal Dominant Juvenile Parkinson Disease
| Article | Year |
|---|---|
Study of antiparkinsonic activity of panavir on a model of Parkinson syndrome induced by systemic administration of MPTP to outbred rats and C57Bl/6 mice.
Topics: Animals; Exploratory Behavior; Locomotion; Mice; Mice, Inbred C57BL; Orientation; Parkinsonian Disor | 2005 |